PREDICTCELL
LIVE

Serial Number

99082365

Owner

Tevogen Bio, Inc.

Attorney

Anna Kurian Shaw

Filing Date

Mar 13, 2025

Add to watchlist:

No watchlists yet
View on USPTO

PREDICTCELL Trademark

Serial Number: 99082365

PREDICTCELL is a trademark filed by Tevogen Bio, Inc. on March 13, 2025. The trademark is classified under Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Tevogen Bio, Inc.

15 Independence Boulevard, Suite 410
Warren, NJ 07059

Entity Type: 03

Trademark Details

Filing Date

March 13, 2025

Registration Date

Not Registered

Published for Opposition

December 9, 2025

Goods & Services

Compilation of information into computer databases in the fields of biotechnology and life sciences; data compilation services being compilation of data into computer databases in the field of scientific, chemical, physical, or biological analysis; compilation of information into computer databases in the field of scientific, chemical, physical, or biological analysis; data processing services in the field of scientific, chemical, physical, or biological analysis; data verification services, namely, updating and maintenance of data in computer databases in the field of scientific, chemical, physical, or biological data; business data analysis services for businesses conducting scientific, chemical, physical, or biological analysis; data processing and business data analysis for businesses generating scientific, chemical, physical, or biological data; database management in the fields of biotechnology and life sciences; database management services, namely, management of databases in the field of scientific, chemical, physical, or biological data; promoting awareness of the benefits of the use of artificial intelligence (AI) technology in the field of biotechnology to expedite drug development, optimize laboratory processes, unravel complex biological data, and improve patient outcomes; promotion and advocacy services, namely promoting awareness of the benefits of the advancement of biomedical, biotechnological, and immunological research and the curing of various diseases utilizing artificial intelligence (AI) technology, by means of public advocacy

Biomanufacturing for others, namely, custom manufacture of pharmaceuticals in the nature of T-cells, using biological materials in the manufacturing process

Scientific research, development, and design of computer software and computer technology in the fields of biotechnology, life sciences, genetic analysis, genome mapping, data analysis, artificial intelligence, and machine learning; computer-aided scientific analysis in the fields of biotechnology, life sciences, genetic analysis, genome mapping, data analytics technology, artificial intelligence, and machine learning; computer modelling services in the fields of biotechnology, life sciences, genetic analysis, genome mapping, data analysis, artificial intelligence, and machine learning; scientific research and analysis in the fields of biotechnology, life sciences, genetic analysis, genome mapping, data analytics technology, artificial intelligence, and machine learning; structural and functional analysis of genomes; genetic mapping for scientific purposes; providing online, non-downloadable computer software for machine learning and training of artificial intelligence models in the fields of biomedical, biotechnological, and immunological research; providing temporary use of non-downloadable computer software for protein sequencing and genome matching; providing temporary use of non-downloadable computer software for identification of protein types and immunological sections of the human genome for scientific research and medical purposes; providing news and information concerning biomedical, biotechnological, and immunological research that utilizes artificial intelligence (AI) technology

Genetic services, namely, genetic counseling and genetic testing for medical purposes; providing a website featuring medical news and medical information concerning biotechnology, biomedicine, immunology, immunotherapies, and T-cell therapies that utilize artificial intelligence (AI) technology

Filing History

NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 3, 2026 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 9, 2025 NPUB
PUBLISHED FOR OPPOSITION
Dec 9, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 3, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 8, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 14, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 10, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 10, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 28, 2025 GNRN
NON-FINAL ACTION E-MAILED
Aug 28, 2025 GNRT
NON-FINAL ACTION WRITTEN
Aug 28, 2025 CNRT
ASSIGNED TO EXAMINER
Aug 14, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 10, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Mar 13, 2025 MAFR
NEW APPLICATION ENTERED
Mar 13, 2025 NWAP